Text Size:AAA

CD86/B7-2 Protein, Antibody, ELISA Kit, cDNA Clone

Description: Active
Expression host: Human Cells
  • Slide 1
10699-H03H-100
10699-H03H-200
100 µg / $198
200 µg / $298
Add to Cart
Description: Active
Expression host: Human Cells
  • Slide 1
10699-H08H-200
10699-H08H-100
200 µg / $298
100 µg / $198
Add to Cart
Description: Active
Expression host: Human Cells
  • Slide 1
50068-M03H-100
50068-M03H-200
100 µg / $198
200 µg / $298
Add to Cart
Description: Active
Expression host: Human Cells
  • Slide 1
50068-M08H-100
50068-M08H-200
100 µg / $178
200 µg / $298
Add to Cart
Description: Active
Expression host: Human Cells
  • Slide 1
80025-R08H-50
80025-R08H-100
50 µg / $178
100 µg / $298
Add to Cart
Expression host: Human Cells
  • Slide 1
90270-C02H-100
90270-C02H-200
100 µg / $198
200 µg / $298
Add to Cart
Expression host: Human Cells
  • Slide 1
90270-C08H-100
90270-C08H-200
100 µg / $198
200 µg / $298
Add to Cart

CD86/B7-2 Related Areas

CD86/B7-2 Related Pathways

CD86/B7-2 Related Product

    CD86/B7-2 Summary & Protein Information

    CD86/B7-2 Background

    Gene Summary: This CD86 gene encodes a type I membrane protein that is a member of the immunoglobulin superfamily. CD86 is expressed by antigen-presenting cells, and it is the ligand for two proteins at the cell surface of T cells, CD28 antigen and cytotoxic T-lymphocyte-associated protein 4. Binding of CD86 with CD28 antigen is a costimulatory signal for activation of the T-cell. Binding of this protein with cytotoxic T-lymphocyte-associated protein 4 negatively regulates T-cell activation and diminishes the immune response. Alternative splicing results in several transcript variants encoding different isoforms.[provided by RefSeq, May 2011]
    General information above from NCBI
    Subunit structure: Homodimer. Interacts with MARCH8. Interacts with human herpesvirus 8 MIR2 protein (Probable). Interacts with adenovirus subgroup B fiber proteins and acts as a receptor for these viruses.
    Subcellular location: Cell membrane; Single-pass type I membrane protein.
    Tissue specificity: Expressed by activated B-lymphocytes and monocytes.
    Post-translational: Polyubiquitinated; which is promoted by MARCH8 and results in endocytosis and lysosomal degradation.
    Sequence similarity: Contains 1 Ig-like C2-type (immunoglobulin-like) domain.
    Contains 1 Ig-like V-type (immunoglobulin-like) domain.
    General information above from UniProt

    CD86, also known as B-lymphocyte activation antigen B7-2 (referred to as B70), is a member of the cell surface immunoglobulin superfamily. B7-2 exists predominantly as a monomer on cell surfaces and interacts with two co-stimulatory receptors CD28 and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) expressed on T cells, and thus induces the signal pathways which regulate T cell activation and tolerance, cytokine production, and the generation of CTL. It is indicated that contacts between B and T helper cells mediated by CD86 encourage signals for the proliferation and IgG secretion of normal B cells and B cell lymphomas. Recent study has revealed that CD86 also promotes the generation of a mature APC repertoire and promotes APC function and survival. CD86 has an important role in chronic hemodialysis, allergic pulmonary inflammation, arthritis, and antiviral responses, and thus is regarded as a promising candidate for immune therapy.

    CD86/B7-2 Alternative Name

    CD86/B7-2 Related Studies

  • Chen YQ, et al. (2006) CD28/CTLA-4--CD80/CD86 and ICOS--B7RP-1 costimulatory pathway in bronchial asthma. Allergy. 61(1): 15-26.
  • Rau FC, et al. (2009) B7-1/2 (CD80/CD86) direct signaling to B cells enhances IgG secretion. J Immunol. 183(12): 7661-71.
  • Dai ZS, et al. (2009) Defective expression and modulation of B7-2/CD86 on B cells in B cell chronic lymphocytic leukemia. Int J Hematol. 89(5): 656-63.
  • Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"